CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205894398
- Phone
- (888) 958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- 4 Planned sale President and CEO sold 20,000 shares at $11.25 ($224,948)
- 4 Planned sale Chief Legal & Compliance sold 42,666 shares at $11.13 ($474,774)
- 4 Open-market sale Director sold 12,300 shares at $11.25 ($138,377)
- 4 Planned sale Chief Legal & Compliance sold 34,557 shares at $12.68 ($438,304)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Legal & Compliance sold 1,794 shares at $11.30 ($20,272)
- 4 Option exercise Director acquired 78,400 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale President and CEO sold 14,625 shares at $8.56 ($125,186)
- 4 Planned sale SVP, Finance & Corp Controller sold 3,000 shares at $9.18 ($27,548)
- 4 Planned sale CCO sold 10,500 shares at $9.19 ($96,500)
- 4 Planned sale SVP, Finance & Corp Controller sold 1,750 shares at $8.82 ($15,442)
- 4 Planned sale Chief Legal & Compliance sold 4,080 shares at $8.83 ($36,010)
Page 1 of 16 · 314 filings